Resting heart rate as a predictor of body weight gain in the early stage of hypertension

Obesity

Volumn 19, Issue 3, 2011, Pages 618-623

  Palatini, Paolo ^a   Mos, Lucio ^b   Santonastaso, Massimo ^b   Zanatta, Nello ^b   Mormino, Paolo ^a   Saladini, Francesca ^a   Bortolazzi, Alessandra ^b   Cozzio, Susanna ^c   Garavelli, Guido ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b Town Hospital   (Italy)

^c Town Hospital   (Italy)

^d Town Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREDICTION; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REST; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 79952005907     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.191     Document Type: Article

References (47)

1. Wang LY, Chyen D, Lee S, Lowry R. The association between body mass index in adolescence and obesity in adulthood. J Adolesc Health 2008;42:512-518.
2. Hedley AA, Ogden CL, Johnson CL et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-2850.
3. Guo SS, Chumlea WC. Tracking of body mass index in children in relation to overweight in adulthood. Am J Clin Nutr 1999;70:145S-148S.
4. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
5. Kannel WB, Zhang T, Garrison RJ. Is obesity-related hypertension less of a cardiovascular risk? The Framingham Study. Am Heart J 1990;120:1195-1201. (Pubitemid 20377295)
6. Rantala AO, Kauma H, Lilja M et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999;245:163-174. (Pubitemid 29089113)
7. Troisi RJ, Weiss ST, Parker DR et al. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669-677.
8. Scherrer U, Randin D, Tappy L et al. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994;89:2634-2640. (Pubitemid 24173681)
9. Grassi G, Seravalle G, Cattaneo BM et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995;25:560-563.
10. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003;41:1072-1079. (Pubitemid 36548605)
11. Tentolouris N, Liatis S, Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2006;1083:129-152. (Pubitemid 44955470)
12. Shigetoh Y, Adachi H, Yamagishi S et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009;22:151-155.
13. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494. (Pubitemid 17092823)
14. Jouven X, Empana JP, Schwartz PJ et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352:1951-1958. (Pubitemid 40638365)
15. Palatini P, Thijs L, Staessen JA et al.; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162:2313-2321. (Pubitemid 35332514)
16. Palatini P, Benetos A, Grassi G et al.; European Society of Hypertension. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006;24:603-610.
17. Hozawa A, Inoue R, Ohkubo T et al. Predictive value of ambulatory heart rate in the Japanese general population: the Ohasama study. J Hypertens 2008;26:1571-1576.
18. Palatini P, Graniero GR, Mormino P et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Circulation 1994;90:2870-2876.
19. Sartori M, Semplicini A, Siffert W et al. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 2003;42:909-914. (Pubitemid 37413729)
20. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004;164:2126-2134. (Pubitemid 39410802)
21. O'Brien E, Petrie J, Littler WA et al. Blood Pressure Measurement: Recommendations of the British Hypertension Society, 3rd edn. BMJ Publishing Group, 1997.
22. Palatini P, Penzo M, Canali C, Pessina AC. Validation of the A&D TM-2420 model 7 for ambulatory blood pressure monitoring and effect of microphone replacement on its performance. J Amb Monitor 1991;4:281-288.
23. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90207 determined by the British Hypertension Society protocol. J Hypertens 1991;9:573-575.
24. Palatini P, Mormino P, Canali C et al. Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Hypertension 1994;23:211-216. (Pubitemid 24050283)
25. Palatini P, Penzo M, Racioppa A et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992;152:1855-1860.
26. Palatini P, Pessina AC, Dal Palù C. The hypertension and Ambulatory Recording Venetia Study (HARVEST): a trial on the predictive value of ambulatory blood pressure monitoring for the development of fixed hypertension in patients with borderline hypertension. High Blood Pressure 1993;21:11-18.
27. Palatini P, Dorigatti F, Santonastaso M et al. Association between coffee consumption and risk of hypertension. Ann Med 2007;39:545-553. (Pubitemid 350035572)
28. Paul L, Hastie CE, Li WS et al. Resting heart rate pattern during follow-up and mortality in hypertensive patients. Hypertension 2010;55:567-574.
29. Kolloch R, Legler UF, Champion A et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 2008;29:1327-1334. (Pubitemid 351768127)
30. Snitker S, Macdonald I, Ravussin E, Astrup A. The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev 2000;1:5-15.
31. Esler M, Rumantir M, Wiesner G et al. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001;14:304S-309S.
32. van Baak MA. The peripheral sympathetic nervous system in human obesity. Obes Rev 2001;2:3-14.
33. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45:9-14. (Pubitemid 40066405)
34. Julius S, Valentini M, Palatini P. Overweight and hypertension: a 2-way street? Hypertension 2000;35:807-813. (Pubitemid 30165330)
35. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997;10:77-83. (Pubitemid 27038975)
36. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474-480. (Pubitemid 37237341)
37. Straznicky NE, Lambert EA, Lambert GW et al. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005;90:5998-6005. (Pubitemid 41606517)
38. Scheidegger K, O'Connell M, Robbins DC, Danforth E Jr. Effects of chronic beta-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones. J Clin Endocrinol Metab 1984;58:895-903. (Pubitemid 14102115)
39. Watanabe T, Nomura M, Nakayasu K et al. Relationships between thermic effect of food, insulin resistance and autonomic nervous activity. J Med Invest 2006;53:153-158.
40. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-381. (Pubitemid 26049592)
41. Muscelli E, Emdin M, Natali A et al. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 1998;83:2084-2090. (Pubitemid 28496341)
42. Valentini M, Julius S, Palatini P et al. Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 2004;22:1999-2006. (Pubitemid 39336684)
43. Grassi G, Vailati S, Bertinieri G et al. Heart rate as marker of sympathetic activity. J Hypertens 1998;16:1635-1639. (Pubitemid 28515490)
44. Mancia G, Bertinieri G, Grassi G et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983;2:695-698. (Pubitemid 13002515)
45. Charkoudian N, Rabbitts JA. Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin Proc 2009;84:822-830.
46. Lambert E, Straznicky N, Eikelis N et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007;25:1411-1419. (Pubitemid 46918828)
47. Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 2001;33:213-221. (Pubitemid 32500402)